Determinant Factors of Osteoporosis Patients' Reported Therapeutic Adherence to Calcium And/or Vitamin D Supplements: a Cross-sectional, Observational Study of Postmenopausal Women

Overview

Journal Drugs Aging

Specialties Geriatrics
Pharmacology

Date 2009 Sep 19

PMID 19761279

Citations 19

Authors

Jose Sanfelix-Genoves

Vicente F Gil-Guillen

Domingo Orozco-Beltran

Vicente Giner-Ruiz

Salvador Pertusa-Martinez

Begona Reig-Moya

Concepcion Carratala

Affiliations

Soon will be listed here.

Abstract

Background: Among the various treatments for osteoporosis, calcium and/or vitamin D supplements are frequently included.

Objective: The objective of the study was to analyse adherence to calcium and/or vitamin D treatment and to identify related predictors of non-adherence in a sample of postmenopausal women treated for osteoporosis in primary care.

Methods: A cross-sectional, observational study was conducted in a sample of postmenopausal women receiving pharmaceutical treatment for osteoporosis with vitamin D and/or calcium. Sociodemographic, general and osteoporosis-related data were collected. Patient's perceptions of the adverse effects of treatment, their knowledge of osteoporosis (Batalla test), their attitude towards treatment (Morisky-Green test) and their self-reported therapeutic adherence (Haynes-Sackett test) were assessed.

Results: Of 630 women (mean age +/- SD 64.1 +/- 8.7 years) evaluated, 36.2% (95% CI 32.4, 39.9) had problems with treatment tolerability, 63.5% (95% CI 59.7, 67.3) had good knowledge of osteoporosis, 20.5% (95% CI 17.3, 23.6) had a good attitude to treatment and 50.0% (95% CI 46.1, 53.9) had good self-reported adherence to treatment. Patients in the poor adherence group had higher mean body mass index (p = 0.014), more concurrent pathologies (p = 0.003), more tolerability problems (p < 0.001) and worse attitude to treatment (p < 0.001). The multivariate model showed a positive relationship between therapeutic adherence and good attitude to treatment (odds ratio [OR] = 11.7; p < 0.001), not having tolerability problems (OR = 3.3; p < 0.001) and no polymedication (OR = 0.80; p = 0.017).

Conclusions: Only one in two postmenopausal women with osteoporosis who take calcium and/or vitamin D have good self-reported therapeutic adherence to this treatment. Determinant factors of adherence to calcium and/or vitamin D treatment were patient's attitude to the treatment, tolerability problems with the treatment and number of concurrent treatments.

Citing Articles

Effects of High Dose Bolus Cholecalciferol on Free Vitamin D Metabolites, Bone Turnover Markers and Physical Function.

Bowles S, Jacques R, Hill T, Eastell R, Walsh J Nutrients. 2024; 16(17).

PMID: 39275206 PMC: 11397043. DOI: 10.3390/nu16172888.

Fixation Using Alternative Implants for the Treatment of Hip Fractures: The feasibility of a multicenter 2 × 2 factorial randomized controlled trial evaluating surgical treatment and vitamin D supplementation in young femoral neck fracture....

Sprague S, Bhandari M, Bzovsky S, Scott T, Thabane L, Heels-Ansdell D OTA Int. 2021; 3(2):e066.

PMID: 33937697 PMC: 8022909. DOI: 10.1097/OI9.0000000000000066.

Factors Predicting the Response to a Vitamin D-Fortified Milk in Healthy Postmenopausal Women.

Reyes-Garcia R, Garcia-Martin A, Palacios S, Salas N, Mendoza N, Quesada-Charneco M Nutrients. 2019; 11(11).

PMID: 31689902 PMC: 6893628. DOI: 10.3390/nu11112641.

Fulminant Skeletal Failure in a Centenarian: The Impact of Nutrition and Immobility.

Brennan M, OFlaherty N, OShea P, OKeeffe S, Mulkerrin E J Nutr Health Aging. 2019; 23(8):700-702.

PMID: 31560026 DOI: 10.1007/s12603-019-1233-7.

A systematic review of factors affecting medication adherence among patients with osteoporosis.

Yeam C, Chia S, Tan H, Kwan Y, Fong W, Seng J Osteoporos Int. 2018; 29(12):2623-2637.

PMID: 30417253 DOI: 10.1007/s00198-018-4759-3.

References

Quesada J, Jans I, Benito P, Jimenez J, Bouillon R . Vitamin D status of elderly people in Spain. Age Ageing. 1989; 18(6):392-7. DOI: 10.1093/ageing/18.6.392. View

van der Wielen R, Lowik M, van den Berg H, de Groot L, Haller J, Moreiras O . Serum vitamin D concentrations among elderly people in Europe. Lancet. 1995; 346(8969):207-10. DOI: 10.1016/s0140-6736(95)91266-5. View

Gaugris S, Heaney R, Boonen S, Kurth H, Bentkover J, Sen S . Vitamin D inadequacy among post-menopausal women: a systematic review. QJM. 2005; 98(9):667-76. DOI: 10.1093/qjmed/hci096. View

Giusti A, Barone A, Razzano M, Oliveri M, Pizzonia M, Palummeri E . Persistence with calcium and vitamin D in elderly patients after hip fracture. J Bone Miner Metab. 2008; 27(1):95-100. DOI: 10.1007/s00774-008-0007-9. View

Larrosa M, Gratacos J, Vaqueiro M, Prat M, Campos F, Roque M . [Prevalence of hypovitaminosis D in elderly institutionalized residents: influence of a substitutive treatment]. Med Clin (Barc). 2001; 117(16):611-4. DOI: 10.1016/s0025-7753(01)72195-1. View

Ortega R, Mena M, Faci M, Santana J, Serra-Majem L . Vitamin status in different groups of the Spanish population: a meta-analysis of national studies performed between 1990 and 1999. Public Health Nutr. 2002; 4(6A):1325-9. DOI: 10.1079/phn2001210. View

Carnevale V, Nieddu L, Romagnoli E, Bona E, Piemonte S, Scillitani A . Osteoporosis intervention in ambulatory patients with previous hip fracture: a multicentric, nationwide Italian survey. Osteoporos Int. 2005; 17(3):478-83. DOI: 10.1007/s00198-005-0010-0. View

Pineiro F, Gil V, Donis M, Orozco D, Torres M, Merino J . [The validity of 6 indirect methods for assessing compliance with pharmacological treatment in dyslipidemias]. Aten Primaria. 1997; 19(9):465-8. View

Alvarez-Nebreda M, Jimenez A, Rodriguez P, Serra J . Epidemiology of hip fracture in the elderly in Spain. Bone. 2007; 42(2):278-85. DOI: 10.1016/j.bone.2007.10.001. View

10.

Aranceta J, Serra-Majem L, Perez-Rodrigo C, Llopis J, Mataix J, Ribas L . Vitamins in Spanish food patterns: the eVe Study. Public Health Nutr. 2002; 4(6A):1317-23. DOI: 10.1079/phn2001209. View

11.

McHorney C, Schousboe J, Cline R, Weiss T . The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates. Curr Med Res Opin. 2007; 23(12):3137-52. DOI: 10.1185/030079907X242890. View

12.

Morisky D, Green L, Levine D . Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986; 24(1):67-74. DOI: 10.1097/00005650-198601000-00007. View

13.

French M, Vernace-Inserra F, Hawker G . A prospective study to identify factors affecting adherence to recommended daily calcium intake in women with low bone mineral density. J Am Coll Nutr. 2008; 27(1):88-95. DOI: 10.1080/07315724.2008.10719679. View

14.

Haynes R, Sackett D, Gibson E, Taylor D, Hackett B, Roberts R . Improvement of medication compliance in uncontrolled hypertension. Lancet. 1976; 1(7972):1265-8. DOI: 10.1016/s0140-6736(76)91737-2. View

15.

Mezquita Raya P, Munoz Torres M, Lopez Rodriguez F, Martinez Martin N, Conde Valero A, Ortego Centeno N . [Prevalence of vitamin D deficiency in populations at risk for osteoporosis: impact on bone integrity]. Med Clin (Barc). 2002; 119(3):85-9. DOI: 10.1016/s0025-7753(02)73327-7. View

16.

Lekkerkerker F, Kanis J, Alsayed N, Bouvenot G, Burlet N, Cahall D . Adherence to treatment of osteoporosis: a need for study. Osteoporos Int. 2007; 18(10):1311-7. DOI: 10.1007/s00198-007-0410-4. View

17.

Boonen S, Rizzoli R, Meunier P, Stone M, Nuki G, Syversen U . The need for clinical guidance in the use of calcium and vitamin D in the management of osteoporosis: a consensus report. Osteoporos Int. 2004; 15(7):511-9. DOI: 10.1007/s00198-004-1621-6. View

18.

Lau E, Papaioannou A, Dolovich L, Adachi J, Sawka A, Burns S . Patients' adherence to osteoporosis therapy: exploring the perceptions of postmenopausal women. Can Fam Physician. 2008; 54(3):394-402. PMC: 2278357. View

19.

Herrera A, Martinez A, Ferrandez L, Gil E, Moreno A . Epidemiology of osteoporotic hip fractures in Spain. Int Orthop. 2005; 30(1):11-4. PMC: 2254671. DOI: 10.1007/s00264-005-0026-2. View

20.

Rizzoli R, Boonen S, Brandi M, Burlet N, Delmas P, Reginster J . The role of calcium and vitamin D in the management of osteoporosis. Bone. 2007; 42(2):246-9. DOI: 10.1016/j.bone.2007.10.005. View